caloreen has been researched along with Kaposi Sarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davies, DS; John, S; Krausz, T; Mason, P; Peers, E; Shaunak, S; Teo, I; Thornton, M | 1 |
Barkley, L; Mason, JC; Shaunak, S; Thornton, M | 1 |
2 trial(s) available for caloreen and Kaposi Sarcoma
Article | Year |
---|---|
Reduction of the viral load of HIV-1 after the intraperitoneal administration of dextrin 2-sulphate in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Dextrins; Dose-Response Relationship, Drug; Drug Administration Schedule; HIV-1; Humans; Immunohistochemistry; Infusions, Parenteral; Macrophage Inflammatory Proteins; Macrophages, Peritoneal; RNA, Viral; Sarcoma, Kaposi; Treatment Outcome; Viral Load; Viremia | 1998 |
Anti-Kaposi's sarcoma and antiangiogenic activities of sulfated dextrins.
Topics: Anti-HIV Agents; Antineoplastic Agents; Dextrins; Endothelium, Vascular; Humans; Injections, Intraperitoneal; Lymphatic System; Neovascularization, Pathologic; Sarcoma, Kaposi; Treatment Outcome | 1999 |